MAMTA PARIKH

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website
openpr.com
·

Urothelial Carcinoma Treatment Market 2034: Clinical Trials

DelveInsight's report on Urothelial Carcinoma Market (2020-2034) highlights market trends, epidemiology, and key companies/therapies. The market size was ~USD 900 million in 2023, expected to grow significantly. Key companies include Merck, Bristol Myers Squibb, and others. Therapies like KEYTRUDA and OPDIVO are prominent. The U.S. leads in market share and incident cases. Pipeline candidates and increased awareness drive market growth.
© Copyright 2024. All Rights Reserved by MedPath